Flat pattern of nephrogenic adenoma: Previously unrecognized pattern unveiled using PAX2 and PAX8 immunohistochemistry

Modern Pathology

Volumn 26, Issue 6, 2013, Pages 792-798

  Piña Oviedo, Sergio ^a   Shen, Steven S ^a,b   Truong, Luan D ^a,b   Ayala, Alberto G ^a,b   Ro, Jae Y ^a,b  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Immunohistochemistry; nephrogenic adenoma; pagetoid spread; PAX2; PAX8; urothelial atypia; variant

Indexed keywords

2 METHYLACYL COENZYME A RACEMASE; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYTOKERATIN 7; TRANSCRIPTION FACTOR PAX2; TRANSCRIPTION FACTOR PAX8;

ADULT; AGED; ARTICLE; BLADDER; BLADDER TUMOR; CLINICAL ARTICLE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; PRIORITY JOURNAL; STROMA; UROTHELIUM;

EID: 84878525949     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2012.239     Document Type: Article

References (18)

1. Banyai-Falger S, Maier U, Susani M, et al. High incidence of nephrogenic adenoma of the bladder after renal transplantation. Transplantation 1998;65:511-514.
2. Amin W, Parwani AV. Nephrogenic adenoma. Pathol Res Pract 2010;206:659-662.
3. Rahemtullah A, Oliva E. Nephrogenic adenoma: an update on an innocuous but troublesome entity Adv Anat Pathol 2006;13:247-255.
4. Fromont G, Barcat L, Gaudin J, et al. Revisiting the immunophenotype of nephrogenic adenoma. Am J Surg Pathol 2009;33:1654-1658.
5. Gupta A, Wang HL, Policarpio-Nicolas ML, et al. Expression of alpha-methylacyl-coenzyme A racemase in nephrogenic adenoma. Am J Surg Pathol 2004;28: 1224-1229.
6. Herlitz LC, Tong GX, Hamele-Bena D, et al. Nephrogenic adenoma identified on urine cytology using PAX-2 immunostaining. Diagn Cytopathol 2008;36:47-49.
7. Pierre-Louis ML, Kovi J, Jackson A, et al. Nephrogenic adenoma: a light and electron microscopic and immunohistochemical study. J Natl Med Assoc 1985;77:201-205.
8. Skinnider BF, Oliva E, Young RH, et al. Expression of alpha-methylacyl-CoA racemase (P504S) in nephrogenic adenoma: a significant immunohistochemical pitfall compounding the differential diagnosis with prostatic adenocarcinoma. Am J Surg Pathol 2004;28:701-705.
9. Ozcan A, Liles N, Coffey D, et al. PAX2 and PAX8 expression in primary and metastatic mullerian epithelial tumors: a comprehensive comparison. Am J Surg Pathol 2011;35:1837-1847.
10. Ozcan A, Shen SS, Hamilton C, et al. PAX 8 expression in non-neoplastic tissues, primary tumors, and metastatic tumors: a comprehensive immunohistochemical study. Mod Pathol 2011;24:751-764.
11. Tong GX, Melamed J, Mansukhani M, et al. PAX2: a reliable marker for nephrogenic adenoma. Mod Pathol 2006;19:356-363.
12. Tong GX, Weeden EM, Hamele-Bena D, et al. Expression of PAX8 in nephrogenic adenoma and clear cell adenocarcinoma of the lower urinary tract: evidence of related histogenesis Am J Surg Pathol 2008;32:1380-1387.
13. Tong GX, Yu WM, Beaubier NT, et al. Expression of PAX8 in normal and neoplastic renal tissues: an immunohistochemical study. Mod Pathol 2009;22: 1218-1227.
14. Hansel DE, Nadasdy T, Epstein JI. Fibromyxoid nephrogenic adenoma: a newly recognized variant mimicking mucinous adenocarcinoma. Am J Surg Pathol 2007;31:1231-1237.
15. Friedman NB, Kuhlenbeck H. Adenomatoid tumors of the bladder reproducing renal structures (nephrogenic adenomas). J Urol 1950;64:657-670.
16. Mazal PR, Schaufler R, Altenhuber-Muller R, et al. Derivation of nephrogenic adenomas from renal tubular cells in kidney-transplant recipients. N Engl J Med 2002;347:653-659.
17. Cheng L, Cheville JC, Sebo TJ, et al. Atypical nephrogenic metaplasia of the urinary tract: a precursor lesion Cancer 2000;88:853-861.
18. Oliva E, Pinheiro NF, Heney NM, et al. Immunohistochemistry as an adjunct in the differential diagnosis of radiation-induced atypia versus urothelial carcinoma in situ of the bladder: a study of 45 cases. Hum Pathol; advance online publication, 27 November 2012 (E-pub ahead of print).